The End-Tidal Carbon Dioxide (EtCO2) Monitoring Nasal Cannula is the company's latest product; it integrates a standard nasal oxygen cannula with an EtCO2 sampling line into a single device, thereby enhancing convenience for clinical use. The EtCO2 sampling line features a standard Luer connector, ensuring compatibility with a wide range of medical devices.
EtCO2 monitoring offers a faster and more sensitive assessment of respiratory status compared to fingertip pulse oximetry.
Expert consensus and clinical guidelines have been established regarding the application of EtCO2 monitoring in various fields, including emergency medicine, tracheal extubation, sedation and anesthesia for gastrointestinal endoscopy in China, post-anesthesia care, and the management of respiratory dysfunction risks during sedation procedures performed outside the operating room.
The ASA (American Society of Anesthesiologists) and the ESA (European Society of Anaesthesiology, 2018) state that EtCO2 monitoring is mandatory for moderate-to-deep sedation (characterized by a loss of consciousness or unresponsiveness to verbal stimuli).
The Expert Consensus on Quality Control in Anesthesiology Departments in China (2021) stipulates that EtCO2 monitoring must be implemented during general anesthesia.
Clinical Anesthesia Monitoring Guidelines identify exhaled carbon dioxide monitoring as a critical indicator of ventilatory function. Consequently, continuous EtCO2 monitoring is mandatory for all patients undergoing general anesthesia.